Cellcyte Genetics Corp (SHPN) Financial Statements (2024 and earlier)

Company Profile

Business Address PMB189
BELLEVUE, WA 98006
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2014
MRQ
12/31/2013
12/31/2012
ASSETS
Current Assets
Prepaid expense and other current assets9,403
Other undisclosed current assets 9,033 
Total current assets: 9,0339,403
Noncurrent Assets
Other undisclosed noncurrent assets  16,218
Total noncurrent assets:  16,218
TOTAL ASSETS: 9,03325,621
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 207,945118,850
Accounts payable 125,540 
Accrued liabilities 82,405118,850
Debt 2,6952,405
Due to related parties 140,704 
Other undisclosed current liabilities  213,713
Total current liabilities: 351,344334,968
Noncurrent Liabilities
Long-term debt and lease obligation 477,489 
Long-term debt, excluding current maturities 477,489 
Total noncurrent liabilities: 477,489 
Total liabilities: 828,833334,968
Equity
Equity, attributable to parent, including: (819,800)11,684,868
Common stock, share subscribed but unissued, subscriptions receivable (49,154)(49,154)
Additional paid in capital 11,734,02211,734,022
Other undisclosed equity, attributable to parent (12,504,668) 
Total equity: (819,800)11,684,868
Other undisclosed liabilities and equity  (11,994,215)
TOTAL LIABILITIES AND EQUITY: 9,03325,621

Income Statement (P&L) (USD)

9/30/2014
TTM
12/31/2013
12/31/2012
Operating expenses (124,149)(132,660)
Other operating expense, net (39,889) 
Operating loss: (164,038)(132,660)
Interest and debt expense  749,539
Income (loss) from continuing operations: (164,038)616,879
Income (loss) before gain (loss) on sale of properties: (164,038)616,879
Other undisclosed net loss  (31,052)
Net income (loss) available to common stockholders, diluted: (164,038)585,827

Comprehensive Income (USD)

9/30/2014
TTM
12/31/2013
12/31/2012
Net income (loss): (164,038)585,827
Comprehensive income (loss), net of tax, attributable to parent: (164,038)585,827

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: